Demyelination during anti-tumour necrosis factor therapy for psoriasis.

Boggs, J M E; Barnes, L

Boggs, J M E; Barnes, L.

Affiliation

Boggs JME; Department of Dermatology, St James's Hospital, Dublin, Ireland.
Barnes L; Department of Dermatology, St James's Hospital, Dublin, Ireland.

Clin Exp Dermatol ; 43(5): 577-578, 2018 Jul.

Article in En | MEDLINE | ID: mdl-29464730

Subject(s)

Adalimumab/adverse effects; Demyelinating Diseases/chemically induced; Demyelinating Diseases/diagnosis; Immunosuppressive Agents/adverse effects; Leukoencephalopathy, Progressive Multifocal/diagnosis; Psoriasis/drug therapy; Adult; Diagnosis, Differential; Female; Humans; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Leukoencephalopathy, Progressive Multifocal / Demyelinating Diseases / Adalimumab / Immunosuppressive Agents Type of study: Diagnostic_studies Limits: Adult / Female / Humans Language: En Journal: Clin Exp Dermatol Year: 2018 Document type: Article

Fulltext

XML

PubMed Links

Search on Google